(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -10.11%140.41B | -14.97%92.98B | -23.27%45.39B | -12.52%192.97B | -10.91%156.21B | -7.36%109.36B | -4.17%59.16B | -8.03%220.58B | 4.64%175.34B | 15.52%118.04B |
Operating income | -10.11%140.41B | -14.97%92.98B | -23.27%45.39B | -12.52%192.97B | -10.91%156.21B | -7.36%109.36B | -4.17%59.16B | -8.03%220.58B | 4.64%175.34B | 15.52%118.04B |
Cost of sales | ---- | 16.13%-71.62B | ---- | 11.46%-151.39B | ---- | 4.53%-85.4B | ---- | 15.11%-170.98B | ---- | -5.15%-89.46B |
Operating expenses | 11.17%-105.06B | 16.13%-71.62B | 24.53%-33.12B | 11.46%-151.39B | 9.13%-118.27B | 4.53%-85.4B | 6.44%-43.88B | 15.11%-170.98B | 5.37%-130.15B | -5.15%-89.46B |
Gross profit | -6.80%35.36B | -10.83%21.36B | -19.65%12.28B | -16.16%41.58B | -16.06%37.94B | -16.20%23.95B | 3.01%15.28B | 29.13%49.6B | 50.47%45.2B | 67.12%28.58B |
Selling expenses | 2.60%-681.31M | 8.18%-418.47M | 24.13%-165.08M | -13.00%-1.05B | -1.75%-699.49M | -22.61%-455.73M | -5.32%-217.59M | -13.47%-928.77M | -8.70%-687.44M | 1.37%-371.68M |
Administrative expenses | -2.20%-3.49B | -4.46%-2.99B | -17.60%-1.27B | -5.97%-7.03B | -12.37%-3.42B | -12.84%-2.87B | -0.12%-1.08B | -17.28%-6.63B | -9.89%-3.04B | -15.94%-2.54B |
Research and development expenses | 11.11%-442.01M | ---- | 4.46%-121.11M | ---- | -4.87%-497.27M | ---- | 4.87%-126.76M | ---- | -35.30%-474.17M | ---- |
Profit from asset sales | 116.32%856K | ---- | -3,705.66%-1.91M | ---- | -204.65%-5.24M | ---- | -98.51%53K | ---- | 128.23%5.01M | ---- |
Impairment and provision | -491.46%-317.42M | -103.03%-76.07M | -14.04%11.77M | 68.60%-68.5M | 97.20%-53.67M | -261.35%-37.47M | -31.43%13.69M | -890.73%-218.17M | -142.64%-1.92B | 53.51%-10.37M |
-Other impairment is provision | -491.46%-317.42M | -103.03%-76.07M | -14.04%11.77M | 68.60%-68.5M | 97.20%-53.67M | -261.35%-37.47M | -31.43%13.69M | -890.73%-218.17M | -142.64%-1.92B | 53.51%-10.37M |
Special items of operating profit | -27.40%1.95B | 39.41%157.62M | -47.58%542.12M | 100.93%78.93M | -34.07%2.69B | 106.31%113.06M | -20.76%1.03B | -153.07%-8.52B | 42.27%4.08B | -3,109.38%-1.79B |
Operating profit | -12.50%26.4B | -12.93%18.03B | -26.89%9.35B | 0.64%33.51B | -19.02%30.17B | -13.25%20.71B | -0.87%12.79B | 16.65%33.3B | 55.56%37.26B | 63.80%23.87B |
Financing income | ---- | 55.00%55.51M | ---- | -22.31%104.99M | ---- | 42.94%35.81M | ---- | 17.92%135.14M | ---- | -53.45%25.06M |
Financing cost | 18.06%-1.88B | 17.30%-1.33B | 12.09%-652.92M | 19.76%-3.1B | 21.51%-2.29B | 21.93%-1.61B | 24.32%-742.76M | 5.12%-3.86B | 1.73%-2.92B | -0.48%-2.06B |
Share of profits of associates | ---- | -40.29%1.23B | ---- | -36.61%3.18B | ---- | -34.77%2.06B | ---- | 52.78%5.01B | ---- | 70.35%3.16B |
Special items of earning before tax | -82.26%3.98M | ---- | -64.72%-12.15M | ---- | 172.64%22.42M | ---- | 62.21%-7.38M | ---- | 112.27%8.22M | ---- |
Earning before tax | -12.10%24.53B | -15.15%17.98B | -27.86%8.68B | -2.57%33.7B | -18.76%27.9B | -15.20%21.19B | 1.17%12.04B | 24.09%34.58B | 64.24%34.34B | 73.20%24.99B |
Tax | 10.32%-5.51B | 12.83%-3.9B | 21.37%-2.06B | 2.75%-7.27B | 18.69%-6.14B | 13.65%-4.48B | -5.13%-2.61B | -13.98%-7.48B | -67.14%-7.55B | -76.35%-5.19B |
After-tax profit from continuing operations | -12.60%19.02B | -15.77%14.08B | -29.66%6.63B | -2.52%26.42B | -18.78%21.76B | -15.60%16.71B | 0.12%9.42B | 27.20%27.1B | 63.45%26.79B | 72.39%19.81B |
Earning after tax | -12.60%19.02B | -15.77%14.08B | -29.66%6.63B | -2.52%26.42B | -18.78%21.76B | -15.60%16.71B | 0.12%9.42B | 27.20%27.1B | 63.45%26.79B | 72.39%19.81B |
Minority profit | -13.15%4.4B | -15.04%3.38B | -26.86%1.66B | -15.31%6.24B | -32.04%5.07B | -24.51%3.98B | -13.40%2.27B | 20.06%7.37B | 66.94%7.46B | 81.03%5.28B |
Profit attributable to shareholders | -12.43%14.61B | -15.99%10.7B | -30.55%4.97B | 2.26%20.18B | -13.66%16.69B | -12.37%12.73B | 5.34%7.16B | 30.09%19.74B | 62.13%19.33B | 69.46%14.53B |
Basic earnings per share | -12.70%1.1 | -15.63%0.81 | -31.48%0.37 | 2.01%1.52 | -13.70%1.26 | -12.73%0.96 | 5.88%0.54 | 30.70%1.49 | 62.22%1.46 | 69.23%1.1 |
Diluted earnings per share | -12.70%1.1 | -15.63%0.81 | -31.48%0.37 | 2.01%1.52 | -13.70%1.26 | -12.73%0.96 | 5.88%0.54 | 30.70%1.49 | 62.22%1.46 | 69.23%1.1 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data